Structural and cellular changes in canine myxomatous mitral valve disease: An image analysis study

Journal of Heart Valve Disease

Volumn 19, Issue 1, 2010, Pages 60-70

  Han, Richard I ^a   Black, Alexander ^b   Culshaw, Geoffrey ^a   French, Anne T ^a   Corcoran, Brendan M ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; ALCIAN BLUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOG; MITRAL VALVE DISEASE; MYXOMATOUS MITRAL VALVE DISEASE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CONNECTIVE TISSUE; FEMALE; IMAGE PROCESSING; MITRAL VALVE; PATHOLOGY; VALVULAR HEART DISEASE;

ALCIAN BLUE; ANIMALS; CELL COUNT; CONNECTIVE TISSUE; DISEASE PROGRESSION; DOGS; FEMALE; GLYCOSAMINOGLYCANS; HEART VALVE DISEASES; IMAGE PROCESSING, COMPUTER-ASSISTED; MITRAL VALVE;

EID: 77950887616     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Darke PG. Valvular incompetence in cavalier King Charles spaniels. Vet Rec 1987;120:365-366
2. Beardovv AW, Buchanan JW. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987-1991). J Am Vet Med Assoc 1993;203:1023-1029
3. Pomerance A, Whitney JC. Heart valve changes common to man and dog: A comparative study. Cardiovasc Res 1970;4:61-66
4. Pedersen HD. Mitral valve prolapse in the dog: Pathogenesis, pathophysiology, diagnosis and comparative aspects of early myxomatous mitral valve disease. Department of Anatomy and Physiology. Copenhagen: The Royal Veterinary and agricultural University, 2000;30
5. Fornes P, Heudes D, Fuzellier JF, et al. Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: A histomorphometric study of 130 excised segments. Cardiovasc Pathol 1999;8:81-92 (Pubitemid 29176911)
6. Buchanan JW. Chronic valvular disease (endocardiosis) in dogs. Adv Vet Sci Comp Med 1977;21:75-106
7. Kogure K. Pathology of chronic mitral valvular disease in the dog. Nippon Juigaku Zasshi 1980;42:323-335
8. Tamura K, Fukuda Y, Ishizaki M, et al. Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am Heart J 1995;129:1149-1158
9. Henney AM, Tsipouras P, Schwartz RC, et al. Genetic evidence that mutations in the COL1A1, COL1A2, COL3A1, or COL5A2 collagen genes are not responsible for mitral valve prolapse. Br Heart J 1989;61:292-299 (Pubitemid 19088479)
10. Lis Y, Burleigh MC, Parker DJ, et al. Biochemical characterization of individual normal, floppy and rheumatic human mitral valves. Biochem J 1987;244:597-603 (Pubitemid 17089823)
11. Murata K. Acidic glycosaminoglycans in human heart valves. J Mol Cell Cardiol 1981;13:281-292 (Pubitemid 11155565)
12. Hadian M, Corcoran BM, Han RI, et al. Collagen organization in canine myxomatous mitral valve disease: An X-ray diffraction study. Biophys J 2007;93:2472-2476 (Pubitemid 47511147)
13. Black A, French AT, Dukes-McEwan J, et al. Ultrastructural morphologic evaluation of the phenotype of valvular interstitial cells in dogs with myxomatous degeneration of the mitral valve. Am J Vet Res 2005;66:1408-1414 (Pubitemid 41613995)
14. Rabkin E, Aikawa M, Stone JR, et al. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001;104:2525-2532 (Pubitemid 33104788)
15. Radermecker MA, Limet R, Lapiere CM, et al. Increased mRNA expression of decorin in the prolapsing posterior leaflet of the mitral valve. Interact Cardiovasc Thorac Surg 2003;2:389-394 (Pubitemid 37040751)
16. Barth PJ, Koster H, Moosdorf R. CD34+ fibrocytes in normal mitral valves and myxomatous mitral valve degeneration. Pathol Res Pract 2005;201:301-304 (Pubitemid 40668480)
17. Han RI, Black A, Culshaw GJ, et al. Distribution of myofibroblasts, smooth muscle-like cells, macrophages, and mast cells in mitral valve leaflets of dogs with myxomatous mitral valve disease. Am J Vet Res 2008;69:763-769 (Pubitemid 351891272)
18. Disatian S, Ehrhart EJ, III, Zimmerman S, et al. Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation. J Heart Valve Dis 2008;17:402-411; discussion 412
19. Cole WG, Bateman JF. Regulation and organization of connective tissues. Aust N Z J Surg 1988;58:263-270
20. Corcoran BM, Black A, Anderson H, et al. Identification of surface morphologic changes in the mitral valve leaflets and chordae tendineae of dogs with myxomatous degeneration. Am J Vet Res 2004;65:198-206 (Pubitemid 38312755)
21. McDonald PC, Wilson JE, Gao M, et al. Quantitative analysis of human heart valves: Does anorexigen exposure produce a distinctive morphological lesion? Cardiovasc Pathol 2002;11:251-262 (Pubitemid 35292241)
22. McDonald PC, Wilson JE, McNeill S, et al. The challenge of defining normality for human mitral and aortic valves: Geometrical and compositional analysis. Cardiovasc Pathol 2002;11:193-209 (Pubitemid 34828271)
23. Whitney JC. Observations on the effect of age on the severity of heart valve lesions in the dog. J Small Anim Pract 1974;15:511-522
24. Cole WG, Chan D, Hickey AJ, et al. Collagen composition of normal and myxomatous human mitral heart valves. Biochem J 1984;219:451-460 (Pubitemid 14136721)
25. Soini Y, Satta J, Maatta M, et al. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. J Pathol 2001;194:225-231
26. Rusted IE, Scheifley CH, Edwards JE. Studies of the mitral valve. I. Anatomic features of the normal mitral valve and associated structures. Circulation 1952;6:825-831
27. Ranganathan N, Lam JH, Wigle ED, et al. Morphology of the human mitral valve. II. The value leaflets. Circulation 1970;41:459-467
28. Kunzelman KS, Cochran RP, Verrier ED, et al. Anatomic basis for mitral valve modeling. J Heart Valve Dis 1994;3:491-496 (Pubitemid 24305455)
29. Grande-Allen KJ, Borowski AG, Troughton RW, et al. Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: An extracellular matrix and echocardiographic study. J Am Coll Cardiol 2005;45:54-61 (Pubitemid 40052025)
30. Timek TA, Lai DT, Dagum P, et al. Mitral leaflet remodeling in dilated cardiomyopathy. Circulation 2006;114:1518-523
31. Grande-Allen KJ, Barber JE, Klatka KM, et al. Mitral valve stiffening in end-stage heart failure: Evidence of an organic contribution to functional mitral regurgitation. J Thorac Cardiovasc Surg 2005;130:783-790 (Pubitemid 41265720)
32. Barber JE, Kasper FK, Ratliff NB, et al. Mechanical properties of myxomatous mitral valves. J Thorac Cardiovasc Surg 2001;122:955-962
33. Kunzelman KS, Cochran RP, Murphree SS, et al. Differential collagen distribution in the mitral valve and its influence on biomechanical behavior. J Heart Valve Dis 1993;2:236-244
34. Hammer D, Leier CV, Baba N, et al. Altered collagen composition in a prolapsing mitral valve with ruptured chordae tendineae. Am J Med 1979;67:863-866 (Pubitemid 10218840)
35. Whittaker P, Boughner DR, Perkins DG, et al. Quantitative structural analysis of collagen in chordae tendineae and its relation to floppy mitral valves and proteoglycan infiltration. Br Heart J 1987;57:264-269 (Pubitemid 17039354)
36. Grande-Allen KJ, Griffin BP, Ratliff NB, et al. Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations. J Am Coll Cardiol 2003;42:271-277 (Pubitemid 36851417)
37. Latif N, Sarathchandra P, Taylor PM, et al. Localization and pattern of expression of extracellular matrix components in human heart valves. J Heart Valve Dis 2005;14:218-227 (Pubitemid 47046901)
38. Fornieri C, Baccarani-Contri M, Quaglino D, Jr., et al. Lysyl oxidase activity and elastin/glycosaminoglycan interactions in growing chick and rat aortas. J Cell Biol 1987;105:1463-1469 (Pubitemid 18029871)